Mental Health Clinics in Parryville, PA Accepting Medicare
1 Mental Health Clinics found. Showing 1 - 1
 Carbon Lehigh Intermediate Unit #21 Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 770 State Rd, Parryville, PA 18244 Phone: 610-769-4111 Fax: 610-769-1168 |
News Archive
First Australian clinic to exclusively diagnose and treat fetal alcohol spectrum disorders
Australia will soon have its first screening and diagnostic service for children with alcohol-related birth defects. The service is being set up by The Children's Hospital at Westmead in Sydney amid concerns that thousands of Australian children are suffering from fetal alcohol spectrum disorders (FASD). The disorders are triggered in unborn babies exposed to alcohol consumed by their mothers and are the most common, preventable cause of disabilities and brain damage in children.
ViroPharma announces results of VP20621 Phase 2 study for preventing recurrent CDI
ViroPharma Incorporated, an international biopharmaceutical company committed to developing and commercializing innovative products that address unmet medical needs and rare diseases, today announced the results of a Phase 2 study of VP20621 (non-toxigenic Clostridium difficile; NTCD) a novel treatment approach for preventing recurrent C. difficile infections.
Manualized equine-assisted therapy shows promise for treating veterans with PTSD
As veterans have high rates of posttraumatic stress disorder (PTSD) and historically poor treatment outcomes and high attrition, alternative treatments have gained much popularity despite lack of rigorous research.
Research provides new insights into the origin of brown fat cells
Scientists from ETH Zurich have shown for the first time that brown and white fat cells in a living organism can be converted from one cell type to the other.
Results of study comparing REMICADE to azathioprine for Crohn's disease published
Findings published today in The New England Journal of Medicine from a first-of-its-kind comparator trial evaluating the anti-tumor necrosis factor (TNF)-alpha biologic treatment REMICADE (infliximab) in the treatment of moderately to severely active Crohn's disease in patients who were naive to immunomodulator and biologic therapy, showed that a significantly greater proportion of patients receiving REMICADE achieved steroid-free remission and mucosal healing compared with patients receiving azathioprine.
› Verified 3 days ago